Details

---

Manufacturer:
-Boehringer Ingelheim Limited, United Kingdom.

Registration Number :
- MAL09062164ARZ
 

Content

• Formulation: Each 2.5 ml single-dose unit contains 500 mcg ipratropium bromide and 3 mg salbutamol sulfate. 

• Appearance: Clear, colourless or almost colourless solution. 

• Excipients: Sodium chloride, hydrochloric acid, and purified water. 

Indications

Combivent UDV 2.5ml is indicated for the management of bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD) who require regular treatment with both ipratropium and salbutamol. 

Instructions 

Administration: For inhalation only via a suitable nebuliser or intermittent positive pressure ventilator. 

• Dosage:

  • Adults (including elderly patients and children over 12 years): 1 single-dose unit (2.5 ml) three or four times daily.

  • Children under 12 years: There is no experience of the use of Combivent UDVs in children under 12 years. 

• Precautions:

  • Use immediately after opening; discard any unused portion.

  • Do not mix with other drugs in the same nebuliser.

  • Avoid contact with eyes to prevent ocular complications. 

• Storage:

  • Store below 25°C.

  • Protect from light.

  • Do not freeze.

  • Keep out of reach of children.